GlaxoSmithKline (GSK) Receives a Buy From Deutsche Numis
Citi Sticks to Their Buy Rating for GlaxoSmithKline (GSK)
UBS Sticks to Its Buy Rating for GlaxoSmithKline (GSK)
GSK Analyst Ratings
Jefferies Maintains Buy on GSK, Raises Price Target to $53
J.P. Morgan Keeps Their Sell Rating on GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK) Gets a Hold From Goldman Sachs
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc
GSK Analyst Ratings
GlaxoSmithKline (GSK) Gets a Buy From Jefferies
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc
Analysts Offer Insights on Healthcare Companies: Agilent (A), GlaxoSmithKline (GSK) and Stryker (SYK)
Analysts Have Conflicting Sentiments on These Healthcare Companies: EBOS Group Limited (AU:EBO), Craneware (GB:CRW) and GlaxoSmithKline (GB:GSK)
GSK Analyst Ratings
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc
GSK Analyst Ratings
Jefferies Upgrades GSK to Buy, Raises Price Target to $48
GSK Analyst Ratings
Berenberg Bank Adjusts GSK Price Target to $41 From $44, Maintains Buy Rating
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc